These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 24937386)
1. Interactions of PPAR α and GLUT4 in DOCA/salt-induced renal injury in mice. Ighodaro I; Eric OK; Adebayo O Niger J Physiol Sci; 2013 Dec; 28(2):127-33. PubMed ID: 24937386 [TBL] [Abstract][Full Text] [Related]
2. NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects. Newaz M; Blanton A; Fidelis P; Oyekan A Mutat Res; 2005 Nov; 579(1-2):163-71. PubMed ID: 16054168 [TBL] [Abstract][Full Text] [Related]
3. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension. Ji X; Naito Y; Weng H; Endo K; Ma X; Iwai N Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1207-15. PubMed ID: 22859404 [TBL] [Abstract][Full Text] [Related]
4. Regulation of blood pressure, natriuresis and renal thiazide/amiloride sensitivity in PPARalpha null mice. Obih P; Oyekan AO Blood Press; 2008; 17(1):55-63. PubMed ID: 18568693 [TBL] [Abstract][Full Text] [Related]
5. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice. Lyu B; Wang W; Ji XY; Ritter JK; Li N BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187 [TBL] [Abstract][Full Text] [Related]
6. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension. Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624 [TBL] [Abstract][Full Text] [Related]
7. Regulation of hypoxia inducible factor/prolyl hydroxylase binding domain proteins 1 by PPARα and high salt diet. Ozurumba E; Mathew O; Ranganna K; Choi M; Oyekan A J Basic Clin Physiol Pharmacol; 2018 Mar; 29(2):165-173. PubMed ID: 29500923 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury. Zhou Y; Kong X; Zhao P; Yang H; Chen L; Miao J; Zhang X; Yang J; Ding J; Guan Y Kidney Int; 2011 Jun; 79(12):1302-11. PubMed ID: 21368746 [TBL] [Abstract][Full Text] [Related]
9. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815 [TBL] [Abstract][Full Text] [Related]
10. [Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype]. Zhu FY; Liu WH; Wang XX; Cui L; Shen S; Zhu MJ; Wang YP Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):488-95. PubMed ID: 25360645 [TBL] [Abstract][Full Text] [Related]
11. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway. Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887 [TBL] [Abstract][Full Text] [Related]
12. mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP. Jia Z; Aoyagi T; Yang T Hypertension; 2010 Feb; 55(2):539-46. PubMed ID: 20065149 [TBL] [Abstract][Full Text] [Related]
13. Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis. Cheng R; Ding L; He X; Takahashi Y; Ma JX Diabetes; 2016 Dec; 65(12):3730-3743. PubMed ID: 27543085 [TBL] [Abstract][Full Text] [Related]
14. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats. Theriot JA; Passmore JC; Jimenez AE; Fleming JT J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649 [TBL] [Abstract][Full Text] [Related]
16. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Silambarasan T; Raja B Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan. Harada M; Kamijo Y; Nakajima T; Hashimoto K; Yamada Y; Shimojo H; Gonzalez FJ; Aoyama T Clin Sci (Lond); 2016 Nov; 130(21):1969-1981. PubMed ID: 27496805 [TBL] [Abstract][Full Text] [Related]
18. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Wang Y; Wang DH Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112 [TBL] [Abstract][Full Text] [Related]
19. Reduced NO production rapidly aggravates renal function through the NF-κB/ET-1/ETA receptor pathway in DOCA-salt-induced hypertensive rats. Kimura K; Ohkita M; Koyama M; Matsumura Y Life Sci; 2012 Oct; 91(13-14):644-50. PubMed ID: 22569294 [TBL] [Abstract][Full Text] [Related]
20. Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice. Gross V; Lippoldt A; Bohlender J; Bader M; Hansson A; Luft FC J Am Soc Nephrol; 1998 Mar; 9(3):346-54. PubMed ID: 9513896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]